First patient recruited for the Actiste® study in the United Kingdom
Brighter AB (publ) (“Brighter” or “The Company'') today announces that in the Actiste[®] clinical-research – being conducted in partnership with the Northern Care Alliance NHS Foundation Trust in the UK city of Salford – the first patient has been recruited and started to use Actiste[®]. The patient will continue to use Actiste[®] for the next six months to check blood glucose and administer insulin and being an IoT device, Actiste[®] automatically records this data. Additional clinically relevant information like meals and physical activity in connection to blood glucose measurements